Overview

• Emma’s year-long struggle began in April 2024 when relentless upper abdominal pain led to an inoperable diagnosis of a rare pancreatic tumour.
• Genetic tests revealed a faulty BRCA2 gene that heightened her cancer risk and helped guide her treatment plan.
• Chemotherapy and radiotherapy have successfully slowed tumour progression but have not rendered it operable.
• She is now weighing irreversible electroporation, an experimental procedure that could reduce the tumour enough to enable surgical removal.
• Emma credits steadfast support from family, friends and her medical team for sustaining her resilience amid fear, hope and uncertainty.